The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in TARDBP, which encodes the transactive response DNA binding protein 43 kDa (TDP-43), are the third most common cause of familial autosomal dominant ALS and account for rare cases of sporadic ALS [290–293].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [291]
In the citing paper
“while mutations in TARDBP (encoding TAR DNA- binding protein 43 [TDP43])306 and FUS (encoding the fused in sarcoma protein) have a lower frequency (<5%).307”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“emphasizing that microglia in the late stage accelerate disease progression.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“and mutations in TARDBP, the gene encoding TDP-43, have been identified in patients with ALS or FTD,306,333 indicating a mechanistic link between TDP-43 and ALS/FTD and also suggesting a common underlying mechanism”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“Reduced mutant levels in microglia did not have much effect on early disease progression, but substantially slowed it later on,306”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. R., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-166 · Cited by 676
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Self-citationTDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S. G., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 474
Self-citationCo-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,011
Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
Godoy, J. A., Ríos, J. A., Picón-Pagès, P., Herrera-Fernández, V., Swaby, B., Crepin, G., Vicente, R., Fernández‐Fernández, J. M., & Muñoz, F. J. (2021) · Biomolecules · doi:10.3390/biom11071012 · Cited by 73
Pathophysiology of Lipid Droplets in Neuroglia
Smolič, T., Zorec, R., & Vardjan, N. (2021) · Antioxidants · doi:10.3390/antiox11010022 · Cited by 71
Wodrich, A. P. K., Scott, A. W., Shukla, A. K., Harris, B. T., & Giniger, E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.831116 · Cited by 73
Engineering enhanced protein disaggregases for neurodegenerative disease
Jackrel, M. E., & Shorter, J. (2015) · Prion · doi:10.1080/19336896.2015.1020277 · Cited by 73
Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS
Shan, X., Vocadlo, D. J., & Krieger, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.031 · Cited by 73
Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology
Whitwell, J. L., & Josephs, K. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.7 · Cited by 73
TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander
Banks, G. T., Kuta, A., Isaacs, A. M., & Fisher, E. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9117-x · Cited by 73
Stem Cell Technology for the Study and Treatment of Motor Neuron Diseases
Lunn, J. S., Sakowski, S. A., Federici, T., Glass, J. D., Boulis, N. M., & Feldman, E. L. (2011) · Regenerative Medicine · doi:10.2217/rme.11.6 · Cited by 72
RNA Dynamics in Alzheimer’s Disease
Rybak‐Wolf, A., & Plass, M. (2021) · Molecules · doi:10.3390/molecules26175113 · Cited by 72
Yin, H., Nalbandian, A., Hsu, C.-I., Li, S., Llewellyn, K. J., Mozaffar, T., Kimonis, V. E., & Weiss, J. H. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.115 · Cited by 72
Genetic therapy for the nervous system
Bowers, W. J., Breakefield, X. O., & Sena‐Esteves, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr110 · Cited by 72
Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort
Nakamura, R., Sone, J., Atsuta, N., Tohnai, G., Watanabe, H., Yokoi, D., Nakatochi, M., Watanabe, H., Ito, M., Senda, J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.030 · Cited by 72
Ditsworth, D., Maldonado, M., McAlonis‐Downes, M., Sun, S., Seelman, A., Drenner, K., Arnold, E. S., Ling, S., Pizzo, D. P., Ravits, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1698-6 · Cited by 72
Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates
Garnier, C., Devred, F., Byrne, D., Puppo, R., Roman, A. Y., Malesinski, S., Golovin, A. V., Lebrun, R., Ninkina, N. N., & Tsvetkov, P. O. (2017) · Scientific Reports · doi:10.1038/s41598-017-07215-7 · Cited by 72
Seilhean, D., Cazeneuve, C., Thuriès, V., Russaouen, O., Millecamps, S., Salachas, F., Meininger, V., LeGuern, E., & Duyckaerts, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0545-9 · Cited by 71
Fecto, F., & Siddique, T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9637-9 · Cited by 71
Genetics of familial Amyotrophic lateral sclerosis.
Ticozzi, N., Tiloca, C., Morelli, C., Colombrita, C., Poletti, B., Doretti, A., Maderna, L., Messina, S., Ratti, A., & Silani, V. (2011) · PubMed · doi:10.4449/aib.v149i1.1262 · Cited by 71
Genin, E. C., Bannwarth, S., Lespinasse, F., Ortega-Vila, B., Fragaki, K., Itoh, K., Villa, E., Lacas‐Gervais, S., Jokela, M. E., Auranen, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.027 · Cited by 71
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS
Vijayakumar, U. G., Milla, V., Stafford, M. Y. C., Bjourson, A. J., Duddy, W. J., & Duguez, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00400 · Cited by 71
Liquid-Liquid Phase Separation in Physiology and Pathophysiology of the Nervous System
Hayashi, Y., Ford, L. K., Fioriti, L., McGurk, L., & Zhang, M. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1656-20.2020 · Cited by 73
Induced pluripotent stem cells from ALS patients for disease modeling
Richard, J., & Maragakis, N. J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.017 · Cited by 71
TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
Guerreiro, R. J., Schymick, J. C., Crews, C. K., Singleton, A., Hardy, J., & Traynor, B. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002450 · Cited by 71
Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
Hasegawa, M., Nonaka, T., & Masuda‐Suzukake, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.010 · Cited by 71
Kovanda, A., Leonardis, L., Zidar, J., Koritnik, B., Dolenc‐Grošelj, L., Kovacic, S. R., Curk, T., & Rogelj, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-23139-2 · Cited by 71
Self-citationTDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease
Neelagandan, N., Gonnella, G., Dang, S., Janiesch, P. C., Miller, K. K., Küchler, K., Marques, R. F., Indenbirken, D., Alawi, M., Grundhoff, A. T., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky972 · Cited by 71
Parallel manifestations of neuropathologies in the enteric and central nervous systems
Natale, G., Pasquali, L., Paparelli, A., & Fornai, F. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01794.x · Cited by 70
TARDBP Mutation Analysis in TDP-43 Proteinopathies and Deciphering the Toxicity of Mutant TDP-43
Gendron, T. F., Rademakers, R., & Petrucelli, L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129036 · Cited by 70
TDP-43: A DNA and RNA binding protein with roles in neurodegenerative diseases
Warraich, S. T., Yang, S., Nicholson, G. A., & Blair, I. P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.016 · Cited by 70
Self-citationGenetic Rodent Models of Amyotrophic Lateral Sclerosis
Bosch, L. V. D. (2011) · BioMed Research International · doi:10.1155/2011/348765 · Cited by 70
Fishing for causes and cures of motor neuron disorders
Patten, S. A., Armstrong, G. A. B., Lissouba, A., Kabashi, E., Parker, J. A., & Drapeau, P. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015719 · Cited by 70
Zhan, L., Xie, Q., & Tibbetts, R. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu493 · Cited by 70
Ayhan, F., Pérez, B., Shorrock, H. K., Zu, T., Báñez-Coronel, M., Reid, T. S., Furuya, H., Clark, H. B., Troncoso, J. C., Ross, C. A., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899023 · Cited by 70
Connecting TDP-43 Pathology with Neuropathy
Klim, J. R., Pintacuda, G., Nash, L. A., Juan, I. G. S., & Eggan, K. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.02.008 · Cited by 70
Piol, D., Robberechts, T., & Cruz, S. D. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.028 · Cited by 68
TDP‐43 and FUS/TLS: cellular functions and implications for neurodegeneration
Fiesel, F. C., & Kahle, P. J. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08258.x · Cited by 69
Coexistence of Huntington’s disease and amyotrophic lateral sclerosis: a clinicopathologic study
Tada, M., Coon, E. A., Osmand, A. P., Kirby, P., Martin, W. R. W., Wieler, M., Shiga, A., Shirasaki, H., Tada, M., Makifuchi, T., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1005-5 · Cited by 69
RNA processing pathways in amyotrophic lateral sclerosis
van Blitterswijk, M., & Landers, J. E. (2010) · Neurogenetics · doi:10.1007/s10048-010-0239-4 · Cited by 69
Moreno, F., Rabinovici, G. D., Karydas, A., Miller, Z., Hsu, S. C., Legati, A., Fong, J. C., Schonhaut, D. R., Esselmann, H., Watson, C., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0190-6 · Cited by 69
Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2
Foran, E., Bogush, A. I., Goffredo, M., Roncaglia, P., Gustincich, S., Pasinelli, P., & Trotti, D. (2011) · Glia · doi:10.1002/glia.21218 · Cited by 69
Lee, J. D., Levin, S. C., Willis, E. F., Li, R., Woodruff, T. M., & Noakes, P. G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1217-2 · Cited by 69
Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis
Ly, C. V., & Miller, T. M. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000594 · Cited by 70
Zacco, E., Martin, S. R., Thorogate, R., & Pastore, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00372 · Cited by 69
Scialò, C., Cecco, E. D., Manganotti, P., & Legname, G. (2019) · Viruses · doi:10.3390/v11030261 · Cited by 69
Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
Ravnik‐Glavač, M., & Glavač, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051714 · Cited by 69
Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
Guerrero, E. N., Mitra, J., Wang, H., Rangaswamy, S., Hegde, P. M., Basu, P., Rao, K. S., & Hegde, M. L. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz062 · Cited by 68
Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology
Ash, P. E. A., Dhawan, U., Boudeau, S., Lei, S., Carlomagno, Y., Knobel, M., Al-Mohanna, L. F. A., Boomhower, S. R., Newland, M. C., Sherr, D. H., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy267 · Cited by 68
Nucleo–cytoplasmic transport defects and protein aggregates in neurodegeneration
Bitetto, G., & Fonzo, A. D. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00205-2 · Cited by 68
Nayab, D. E., Din, F. U., Ali, H., Kausar, W. A., Urooj, S., Zafar, M., Khan, I., Shabbir, K., & Khan, G. M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02250-1 · Cited by 68
MicroRNA in skeletal muscle development, growth, atrophy, and disease
Kovanda, A., Režen, T., & Rogelj, B. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1227 · Cited by 68
Self-citationSOD1 mRNA expression in sporadic amyotrophic lateral sclerosis
Gagliardi, S., Cova, E., Davin, A., Guareschi, S., Abel, K. J., Alvisi, E., Laforenza, U., Ghidoni, R., Cashman, J. R., Ceroni, M., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.008 · Cited by 68
Marco, G. D., Lupino, E., Calvo, A., Moglia, C., Buccinnà, B., Grifoni, S., Ramondetti, C., Lomartire, A., RINAUDO, M. T., Piccinini, M., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0786-7 · Cited by 68
Yu, Z., Fan, D., Gui, B., Shi, L., Xuan, C., Shan, L., Wang, Q., Shang, Y., & Wang, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357582 · Cited by 68
Boyd, J. D., Lee-Armandt, J. P., Feiler, M. S., Zaarur, N., Liu, M., Kraemer, B. C., Concannon, J. B., Ebata, A., Wolozin, B. L., & Glicksman, M. A. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113501553 · Cited by 68
Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction
Cannon, A. D., Yang, B., Knight, J. A., Farnham, I. M., Zhang, Y., Wuertzer, C. A., D’Alton, S., Lin, W.-L., Castanedes‐Casey, M., Rousseau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0979-3 · Cited by 68
The Enigmatic Role of C9ORF72 in Autophagy
Nassif, M., Woehlbier, U., & Manque, P. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00442 · Cited by 68
Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 68
Deng, H.-X. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.178 · Cited by 67
Multisystem proteinopathy: Where myopathy and motor neuron disease converge
Korb, M. K., Kimonis, V. E., & Mozaffar, T. (2020) · Muscle & Nerve · doi:10.1002/mus.27097 · Cited by 67
Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids
Tamaki, Y., Ross, J. P., Alipour, P., Castonguay, C.-E., Li, B., Catoire, H., Rochefort, D. L., Urushitani, M., Takahashi, R., Sonnen, J. A., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010606 · Cited by 67
Research progress on the role of extracellular vesicles in neurodegenerative diseases
Li, Z., Wang, X., Wang, X., Yi, X., Wong, Y. K., Wu, J., Xie, F., Hu, D., Wang, Q., Wang, J., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00375-9 · Cited by 67
Broeck, L. V., Naval-Sánchez, M., Adachi, Y., Diaper, D. C., Dourlen, P., Chapuis, J., Kleinberger, G., Gistelinck, M., Broeckhoven, C. V., Lambert, J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.014 · Cited by 67
Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit
Guest, W. C., Silverman, J. M., Pokrishevsky, E., O’Neill, M. A., Grad, L. I., & Cashman, N. R. (2011) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2011.618967 · Cited by 67
Ber, I. L., van Bortel, I., Nicolas, G., Bouya-Ahmed, K., Camuzat, A., Wallon, D., de Septenville, A. L., Latouche, M., Lattante, S., Kabashi, E., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.016 · Cited by 67
TDP-43 Regulates the Microprocessor Complex Activity During In Vitro Neuronal Differentiation
Carlo, V. D., Grossi, E., Laneve, P., Morlando, M., Modigliani, S. D., Ballarino, M., Bozzoni, I., & Caffarelli, E. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8564-x · Cited by 67
RNA‐binding proteins in neurodegenerative disease: TDP‐43 and beyond
Hanson, K. A., Kim, S. H., & Tibbetts, R. S. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.111 · Cited by 68
Kwok, C. T., Morris, A. G., & de Belleroche, J. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.184 · Cited by 67
Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis
González-Pérez, P., Cirulli, E. T., Drory, V. E., Dabby, R., Nisipeanu, P., Carasso, R. L., Sadeh, M., Fox, A., Festoff, B. W., Sapp, P. C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318275963b · Cited by 67
Mihevc, S. P., Baralle, M., Buratti, E., & Rogelj, B. (2016) · Scientific Reports · doi:10.1038/srep33996 · Cited by 67
Self-citationProteostasis disturbance in amyotrophic lateral sclerosis
Medinas, D. B., Valenzuela, V., & Hetz, C. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx274 · Cited by 67
microRNAs in Neurodegeneration: Current Findings and Potential Impacts
Sharma, S., & Lu, H. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000420 · Cited by 67
Cozzolino, M., Pesaresi, M. G., Gerbino, V., Großkreutz, J., & Carrı̀, M. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4328 · Cited by 66
Chiò, A., Calvo, A., Moglia, C., Restagno, G., Ossola, I., Brunetti, M., Montuschi, A., Cistaro, A., Ticca, A., Traynor, B. J., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.173 · Cited by 66
RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse
Bandyopadhyay, U., Cotney, J. L., Nagy, M., Oh, S., Leng, J., Mahajan, M. C., Mane, S., Fenton, W. A., Noonan, J. P., & Horwich, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053575 · Cited by 66
FUS-related proteinopathies: Lessons from animal models
Lanson, N. A., & Pandey, U. B. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.039 · Cited by 66
Gendron, T. F., & Petrucelli, L. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9610-7 · Cited by 66
Kryndushkin, D. S., Ihrke, G., Piermartiri, T., & Shewmaker, F. P. (2012) · Molecular Microbiology · doi:10.1111/mmi.12075 · Cited by 66
Tanaka, Y., Nonaka, T., Suzuki, G., Kametani, F., & Hasegawa, M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw024 · Cited by 66
Defining the spectrum of frontotemporal dementias associated with TARDBP mutations
Caroppo, P., Camuzat, A., Guillot‐Noël, L., Thomas-Antérion, C., Couratier, P., Wong, T. H., Teichmann, M., Golfier, V., Auriacombe, S., Belliard, S., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000080 · Cited by 66
The phosphatase calcineurin regulates pathological TDP-43 phosphorylation
Liachko, N. F., Saxton, A. D., McMillan, P. J., Strovas, T. J., Currey, H. N., Taylor, L. M., Wheeler, J. M., Oblak, A. L., Ghetti, B. F., Montine, T. J., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1600-y · Cited by 66
Autophagy in neuroinflammatory diseases
Muller, S., Brun, S., René, F., Seze, J. D., Loeffler, J., & Jeltsch‐David, H. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.015 · Cited by 66
Chi, B., O’Connell, J. D., Yamazaki, T., Gangopadhyay, J. P., Gygi, S. P., & Reed, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-27136-3 · Cited by 66
CRISPR/Cas9-Mediated Gene Correction to Understand ALS
Yun, Y., & Ha, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113801 · Cited by 66
From nucleation to widespread propagation: A prion-like concept for ALS
Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65
ALS: Recent Developments from Genetics Studies
Therrien, M., Dion, P. A., & Rouleau, G. A. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0658-1 · Cited by 65
TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
Turner, B. J., Bäumer, D., Parkinson, N., Scaber, J., Ansorge, O., & Talbot, K. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-104 · Cited by 65
ALS pathogenesis: Recent insights from genetics and mouse models
Swarup, V., & Julien, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.006 · Cited by 65
TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice
Tian, T., Huang, C., Tong, J., Yang, M., Zhou, H., & Xia, X. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.234 · Cited by 65
Clark, J. A., Yeaman, E. J., Blizzard, C. A., Chuckowree, J. A., & Dickson, T. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00204 · Cited by 66
Splicing regulatory factors, ageing and age-related disease
Latorre, E., & Harries, L. W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.04.004 · Cited by 65
Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
Ferrara, D., Pasetto, L., Bonetto, V., & Basso, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00574 · Cited by 65
Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains
Yin, P., Guo, X., Yang, W., Yan, S., Yang, S., Zhao, T., Sun, Q., Liu, Y., Li, S., & Li, X. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01979-0 · Cited by 65
Nuclear bodies in neurodegenerative disease
Woulfe, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.005 · Cited by 65
Gelon, P. A., Dutchak, P. A., & Sephton, C. F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1000183 · Cited by 64
Miro1 deficiency in amyotrophic lateral sclerosis
Zhang, F., Wang, W., Siedlak, S. L., Liu, Y., Liu, J., Jiang, K., Perry, G. L., Zhu, X., & Wang, X. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00100 · Cited by 64
Patel, P., Julien, J., & Križ, J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0311-0 · Cited by 64
CSF markers in amyotrophic lateral sclerosis
Tarasiuk, J., Kułakowska, A., Drozdowski, W., Kornhuber, J., & Lewczuk, P. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0806-y · Cited by 64
Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders
Bartolomucci, A., Pasinetti, G. M., & Salton, S. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.057 · Cited by 64
Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport
Štalekar, M., Yin, X., Rebolj, K., Darovic, S., Troakes, C., Mayr, M., Shaw, C. E., & Rogelj, B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.046 · Cited by 64
Self-citationMutational analysis of TARDBP in neurodegenerative diseases
Ticozzi, N., LeClerc, A. L., van Blitterswijk, M., Keagle, P. J., McKenna-Yasek, D. M., Sapp, P. C., Silani, V., Wills, A.-M. A., Brown, R. H., & Landers, J. E. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.018 · Cited by 64
Metadata
- Authors
- Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C., Nicholson, G., & Shaw, C. E.
- Affiliations
- The University of Sydney (AU)
- Department of Clinical Neuroscience, King's College London, Medical Research Council (MRC) Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
- Corresponding author
- Sreedharan, Jemeen
- Blair, Ian P.
- Tripathi, Vineeta B.
- Nicholson, Garth
- Shaw, Christopher E.
- ORCID
- Venue
- Science
- Published
- 2008-03-21
- Volume
- 319
- Issue
- 5870
- Pages
- 1668-1672
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7116650
- OpenAlex
- W1619082318
- Cited by
- 2,630
- References
- 29
- Citations by year
- 2026: 73 · 2025: 88 · 2024: 104 · 2023: 141 · 2022: 149 · 2021: 141 · 2020: 149 · 2019: 121 · 2018: 147 · 2017: 117 · 2016: 156 · 2015: 154 · 2014: 167 · 2013: 168 · 2012: 192
- FWCI
- 119.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- Wellcome Trust (076671)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, TDP-43, TARDBP, familial ALS, sporadic ALS, TDP-43 mutations, chromosome 1p36, genetic linkage, ubiquitinated inclusions, neurodegeneration, neuronal apoptosis, protein fragmentation
- MeSH terms
- Adult, Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Chick Embryo, Chromosomes, Human, Pair 1, Cricetulus, DNA-Binding Proteins, Female, Cricetinae, Humans, Male, Middle Aged, Molecular Sequence Data, Neurons, CHO Cells, Apoptosis, Microsatellite Repeats, Amino Acid Substitution, Mutation, Missense, Embryonic Development, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review